European Pharmaceutical Review

MARCH 27, 2024

percent from 2023 to 2032, according to the research. Drivers of the pyrogen testing market Increased R&D activities within the pharmaceutical and biopharmaceutical sector and a focus on biologics, were reported to hold significant growth opportunities for the pyrogen testing market. billion by 2032.

Safety 94

Safety Marketing Food and Drug Administration Pharmaceutical 94

European Pharmaceutical Review

MAY 28, 2024

Considering material type, glass ampoule packaging was found to hold a market share of around 77 percent in 2023, in comparison to plastic. This can raise safety concerns for patients, due to important information not being present on the packaging, the report stated.

Marketing 97

Marketing Transportation Distribution Pharmaceutical products 97

European Pharmaceutical Review

APRIL 17, 2023

percent during the forecast period 2023-2033. million in 2023, according to the data. Factors impacting the automation in the biopharma industry market The report found that 75 percent of pharmaceutical organisations want to use automated solutions more frequently. The market’s overall world revenue value will exceed $1,855.0

Biopharma 98

Biopharma Manufacturing Pharmaceutical products Marketing 98

European Pharmaceutical Review

JANUARY 26, 2023

These concentration measurements are used as part of regulatory decisions regarding the safety and efficacy of medicinal products. Implementation of the ICH M10 document The EU date of coming into effect of the core ICH M10 document and the corresponding Q&As was 21 January 2023.

Food and Drug Administration 98

Food and Drug Administration Medicine Pharmaceutical products Pharmaceutical 98

Pharmaceutical Technology

MARCH 22, 2023

Various uses soon became apparent including those for supply chain management, anti-counterfeiting, and to improve patient safety. In the US Drug Quality and Security Act (DSCSA), the FDA mandates that manufacturers and trading partners should have full interoperable electronic track and trace systems in place by November 2023.

Food and Drug Administration 105

Food and Drug Administration Electronics Pharma Pharmaceutical products 105

European Pharmaceutical Review

DECEMBER 23, 2024

14 This in turn has led to the introduction of safety-based limits, 15 eg, permitted daily exposures (PDEs), etc. ICH Q6A 1 states that specifications should focus on those characteristics found to be useful in ensuring the safety and efficacy of the drug substance and drug product. 3 February 2023. 3 March 2023.

Safety 52

Safety Pharmaceutical Manufacturing Management 52

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. market (source: IQVIA MIDAS, May 2023). billion people in 2023). in the top five European Union markets and 7.1%

Marketing 105

Marketing Insurance Medical Manufacturing 105